BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32376739)

  • 1. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
    Maestá I; de Freitas Segalla Moreira M; Rezende-Filho J; Bianconi MI; Jankilevich G; Otero S; Correa Ramirez LA; Sun SY; Elias K; Horowitz N; Braga A; Berkowitz R
    Int J Gynecol Cancer; 2020 Sep; 30(9):1366-1371. PubMed ID: 32376739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
    Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
    Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia.
    Soares RR; Maestá I; Colón J; Braga A; Salazar A; Charry RC; Sun SY; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 2016 Sep; 142(3):496-500. PubMed ID: 27423380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study.
    Freitas F; Braga A; Viggiano M; Velarde LGC; Maesta I; Uberti E; Madi JM; Yela D; Fernandes K; Silveira E; Leal E; Sun SY; Dos Santos Esteves APV; Filho JR; Junior JA; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Aug; 158(2):452-459. PubMed ID: 32402634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia.
    Ramírez LAC; Maestá I; Bianconi MI; Jankilevich G; Otero S; Mejía CRV; Cortés-Charry R; Elias KM; Horowitz NS; Seckl M; Berkowitz RS
    Rev Bras Ginecol Obstet; 2022 Aug; 44(8):746-754. PubMed ID: 35760362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
    Oranratanaphan S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.
    Braga A; Lopes R; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; de Sousa CB; Leal E; Yela D; Uberti E; Madi JM; Viggiano M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Sep; 176():130-138. PubMed ID: 37524011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
    Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia].
    Cheng HY; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):390-394. PubMed ID: 32842245
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review.
    Lin LH; Maestá I; Braga A; Sun SY; Fushida K; Francisco RPV; Elias KM; Horowitz N; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 2017 Apr; 145(1):88-95. PubMed ID: 28132722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.